Piao J-L, Jin Y-J, Li M-L, Zakki S A, Sun L, Feng Q-W, Zhou D, Kondo T, Cui Z-G, Inadera H
Graduate School of Medicine, Henan Polytechnic University, Jiaozuo 454000, China.
Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Curr Mol Med. 2018;18(5):322-334. doi: 10.2174/1566524018666181024161704.
Hyperthermia (HT) has been used widely for cancer therapy, and the development of modern devices has made it more efficient. Shikonin (SHK) is a natural naphthoquinone derivative from a Chinese herb. Although the anticancer properties of SHK are evident, the underlying molecular mechanisms are not fully understood.
In this study, the effects of combining low doses of SHK with mild HT were investigated in the U937 cell line.
The cells were subjected to HT at 44°C for 10 min with or without SHK pretreatment, and parameters reflecting apoptosis, ROS generation and intracellular calcium elevation were evaluated by using DNA fragmentation, flow cytometry, and western blot analyses.
SHK 0.5 µM significantly enhanced HT-induced apoptosis as indicated by DNA fragmentation and caspase-3 activation with increased generation of ROS and elevation of intracellular calcium. The combined treatment also synergistically activated proapoptotic proteins and inactivated anti-apoptotic proteins. Furthermore, the phosphorylation of JNK and PKC- δ and the dephosphorylation of ERK and AKT were the upstream effects that may have compounded the induction of apoptosis. The modulatory effects of HT and SHK were abrogated with the employment of NAC and JNK-IN-8 by inactivating the MAPK pathway and cleavage of caspase-3. Intracellular calcium was also elevated and was found to be responsible for the induction of cell death evident by the DNA fragmentation with or without the employment of BAPTA-AM.
Conclusively, this study provides persuasive evidence that SHK in combination with HT is a propitious therapeutic way for augmentation of apoptosis and hence suggest a novel strategy for treating cancers.
热疗(HT)已被广泛用于癌症治疗,现代设备的发展使其更加高效。紫草素(SHK)是一种来自中药的天然萘醌衍生物。尽管紫草素的抗癌特性明显,但其潜在的分子机制尚未完全了解。
本研究在U937细胞系中研究了低剂量紫草素与轻度热疗联合应用的效果。
细胞在有或没有紫草素预处理的情况下于44°C进行10分钟热疗,通过DNA片段化、流式细胞术和蛋白质印迹分析评估反映细胞凋亡、活性氧生成和细胞内钙升高的参数。
0.5μM紫草素显著增强了热疗诱导的细胞凋亡,表现为DNA片段化和半胱天冬酶-3激活,同时活性氧生成增加和细胞内钙升高。联合治疗还协同激活促凋亡蛋白并使抗凋亡蛋白失活。此外,JNK和PKC-δ的磷酸化以及ERK和AKT的去磷酸化是可能加剧细胞凋亡诱导的上游效应。通过使MAPK途径失活和半胱天冬酶-3裂解,使用NAC和JNK-IN-8消除了热疗和紫草素的调节作用。细胞内钙也升高,并且发现无论是否使用BAPTA-AM,细胞内钙都与DNA片段化所显示的细胞死亡诱导有关。
总之,本研究提供了有说服力的证据,表明紫草素与热疗联合应用是增强细胞凋亡的一种有利治疗方法,因此提出了一种治疗癌症的新策略。